Details of the Drug Combinations

General Information of This Drug (ID: DM5JVS3)

Drug Name
Isoniazid   DM5JVS3
Synonyms
Abdizide; Andrazide; Anidrasona; Antimicina; Antituberkulosum; Armacide; Armazid; Armazide; Atcotibine; Azuren; Bacillen; Bacillin; Cedin; Cemidon; Chemiazid; Chemidon; Continazine; Cortinazine; Cotinazin; Cotinizin; Defonin; Dibutin; Diforin; Dinacrin; Ditubin; Ebidene; Eralon; Ertuban; Eutizon; Evalon; Fetefu; Fimalene; HIA; Hidranizil; Hidrasonil; Hidrulta; Hidrun; Hycozid; Hydra; Hydrazid; Hydrazide; Hyozid; Hyzyd; INH; Idrazil; Inah; Inizid; Iscotin; Isidrina; Ismazide; Isobicina; Isocid; Isocidene; Isocotin; Isohydrazide; Isokin; Isolyn; Isonerit; Isonex; Isoniacid; Isoniazida; Isoniazide; Isoniazidum; Isonicazide; Isonicid; Isonico; Isonicotan; Isonicotil; Isonicotinhydrazid; Isonicotinohydrazide; Isonide; Isonidrin; Isonikazid; Isonilex; Isonin; Isonindon; Isonirit; Isoniton; Isonizida; Isonizide; Isotamine; Isotebe; Isotebezid; Isotinyl; Isozid; Isozide; Isozyd; LANIZID; Laniazid; Laniozid; Mybasan; Neoteben; Neoxin; Neumandin; Nevin; Niadrin; Nicazide; Nicetal; Nicizina; Niconyl; Nicotibina; Nicotibine; Nicotisan; Nicozide; Nidaton; Nidrazid; Nikozid; Niplen; Nitadon; Niteban; Nydrazid; Nyscozid; Pelazid; Percin; Phthisen; Pycazide; Pyreazid; Pyricidin; Pyridicin; Pyrizidin; Raumanon; Razide; Retozide; Rimicid; Rimifon; Rimiphone; Rimitsid; Robiselin; Robisellin; Roxifen; Sanohidrazina; Sauterazid; Sauterzid; Stanozide; Tebecid; Tebemid; Tebenic; Tebexin; Tebilon; Tebos; Teebaconin; Tekazin; Tibazide; Tibemid; Tibiazide; Tibinide; Tibison; Tibivis; Tibizide; Tibusan; Tisin; Tisiodrazida; Tizide; Tubazid; Tubazide; Tubeco; Tubecotubercid; Tubercid; Tuberian; Tubicon; Tubilysin; Tubizid; Tubomel; Tyvid; Unicocyde; Unicozyde; Vazadrine; Vederon; Zidafimia; Zinadon; Zonazide; Hid rasonil; Isoco tin; Isoniazid SA; Isozid e; Nidra zid; Rimif on; BP 5015; Bp 5 015; FSR 3; I0138; INHd20; L 1945; Nitebannsc 9659; Preparation 6424; RP 5015; AZT + Isoniazid; Cedin (Aerosol); Dow-Isoniazid; FRS-3; FSR-3; Ido-tebin; In-73; Inh-Burgthal; Isoniazid & EEP; Isoniazid & Propolis; Laniazid (TN); Neo-Tizide; Nydrazid (TN); RP-5015; TB-Phlogin; TB-Razide; TB-Vis; Usaf cb-2; I.A.I; RU-EF-Tb; RY-EF-Tb; I.A.I.
Indication
Disease Entry ICD 11 Status REF
Latent tuberculosis infection N.A. Approved [1]
Pulmonary tuberculosis 1B10.Z Approved [1]
Tuberculosis 1B10-1B1Z Approved [2]
Therapeutic Class
Antitubercular Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

380 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
ABIRATERONE + Isoniazid DCORH5O ABIRATERONE Clear cell renal cell carcinoma (Cell Line: A498) [3]
ABIRATERONE + Isoniazid DCP0AXY ABIRATERONE Glioblastoma (Cell Line: SNB-75) [3]
ABIRATERONE + Isoniazid DC477Q5 ABIRATERONE Renal cell carcinoma (Cell Line: UO-31) [3]
ABIRATERONE + Isoniazid DCRPQ0A ABIRATERONE Invasive ductal carcinoma (Cell Line: BT-549) [4]
ABIRATERONE + Isoniazid DC2XM01 ABIRATERONE Adenocarcinoma (Cell Line: DU-145) [5]
ABIRATERONE + Isoniazid DCU9CBT ABIRATERONE Melanoma (Cell Line: SK-MEL-2) [5]
ABIRATERONE + Isoniazid DC57W56 ABIRATERONE Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
ABIRATERONE + Isoniazid DC8D55B ABIRATERONE Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Altretamine + Isoniazid DCHQN4M Altretamine Adenocarcinoma (Cell Line: A549) [3]
Altretamine + Isoniazid DC0U4DO Altretamine Adenocarcinoma (Cell Line: HT29) [3]
Altretamine + Isoniazid DCA38RU Altretamine Adenocarcinoma (Cell Line: SW-620) [3]
Altretamine + Isoniazid DCXJB1U Altretamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Altretamine + Isoniazid DCUEG12 Altretamine Anaplastic large cell lymphoma (Cell Line: SR) [3]
Altretamine + Isoniazid DCUQVB5 Altretamine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Altretamine + Isoniazid DCTY59O Altretamine Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Altretamine + Isoniazid DC72VBD Altretamine Glioma (Cell Line: SF-295) [3]
Altretamine + Isoniazid DC4Z9W0 Altretamine Melanoma (Cell Line: SK-MEL-2) [3]
Anastrozole + Isoniazid DC7UZEJ Anastrozole Adenocarcinoma (Cell Line: HCC-2998) [3]
Anastrozole + Isoniazid DCEXJK3 Anastrozole Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Anastrozole + Isoniazid DCYQBBK Anastrozole Amelanotic melanoma (Cell Line: M14) [3]
Anastrozole + Isoniazid DCRDS7X Anastrozole Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Anastrozole + Isoniazid DCI1VK2 Anastrozole Chronic myelogenous leukemia (Cell Line: K-562) [3]
Anastrozole + Isoniazid DCLR88P Anastrozole Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Anastrozole + Isoniazid DCCMB1S Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Anastrozole + Isoniazid DCBBY3T Anastrozole High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Anastrozole + Isoniazid DCLH5G2 Anastrozole Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Anastrozole + Isoniazid DCYLDPE Anastrozole Lung adenocarcinoma (Cell Line: EKVX) [3]
Anastrozole + Isoniazid DC5CXHB Anastrozole Melanoma (Cell Line: UACC-257) [3]
Anastrozole + Isoniazid DCWAO3Q Anastrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Anastrozole + Isoniazid DCPWRRF Anastrozole Papillary renal cell carcinoma (Cell Line: ACHN) [3]
Anastrozole + Isoniazid DCJQUM7 Anastrozole Prostate carcinoma (Cell Line: PC-3) [3]
Anastrozole + Isoniazid DCSKABH Anastrozole Renal cell carcinoma (Cell Line: UO-31) [3]
Anastrozole + Isoniazid DC37Q4X Anastrozole Carcinoma (Cell Line: RXF 393) [4]
Anastrozole + Isoniazid DC6V0KB Anastrozole Carcinoma (Cell Line: MCF7) [4]
Anastrozole + Isoniazid DCYX8AP Anastrozole Colon carcinoma (Cell Line: KM12) [4]
Anastrozole + Isoniazid DC4KJ9Z Anastrozole Invasive ductal carcinoma (Cell Line: T-47D) [4]
Anastrozole + Isoniazid DC0T6OY Anastrozole Invasive ductal carcinoma (Cell Line: BT-549) [4]
Anastrozole + Isoniazid DCNCBGY Anastrozole Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Arfolitixorin + Isoniazid DC5DTTR Arfolitixorin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Arfolitixorin + Isoniazid DCGIO1W Arfolitixorin Colon carcinoma (Cell Line: KM12) [4]
Azacitidine + Isoniazid DCNOSZ4 Azacitidine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Azacitidine + Isoniazid DCGULA9 Azacitidine Lung adenocarcinoma (Cell Line: HOP-62) [3]
Bendamustine hydrochloride + Isoniazid DC65HIV Bendamustine hydrochloride Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bendamustine hydrochloride + Isoniazid DCXBJNH Bendamustine hydrochloride Chronic myelogenous leukemia (Cell Line: K-562) [3]
Bendamustine hydrochloride + Isoniazid DCGOZOI Bendamustine hydrochloride Glioma (Cell Line: SF-539) [3]
Bendamustine hydrochloride + Isoniazid DCSJ91U Bendamustine hydrochloride Renal cell carcinoma (Cell Line: UO-31) [3]
Bendamustine hydrochloride + Isoniazid DC8TEP0 Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bendamustine hydrochloride + Isoniazid DCLY4O5 Bendamustine hydrochloride Invasive ductal carcinoma (Cell Line: BT-549) [4]
Bendamustine hydrochloride + Isoniazid DC37YIP Bendamustine hydrochloride Adenocarcinoma (Cell Line: OVCAR3) [5]
Bendamustine hydrochloride + Isoniazid DCEMLJ3 Bendamustine hydrochloride Adenocarcinoma (Cell Line: A549) [5]
Bendamustine hydrochloride + Isoniazid DCN2ZBM Bendamustine hydrochloride Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Bendamustine hydrochloride + Isoniazid DCVSL3P Bendamustine hydrochloride Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Bendamustine hydrochloride + Isoniazid DC7KW8V Bendamustine hydrochloride Prostate carcinoma (Cell Line: PC-3) [5]
Bleomycin + Isoniazid DCGINLN Bleomycin Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Bleomycin + Isoniazid DCA962R Bleomycin Invasive ductal carcinoma (Cell Line: T-47D) [4]
Bleomycin + Isoniazid DCQQ1N6 Bleomycin Adenocarcinoma (Cell Line: A549) [5]
Bleomycin + Isoniazid DCCF0HM Bleomycin Adenocarcinoma (Cell Line: HCC-2998) [5]
Busulfan + Isoniazid DCR7R33 Busulfan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Busulfan + Isoniazid DCC7CE9 Busulfan Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Crizotinib + Isoniazid DCFKICD Crizotinib Adenocarcinoma (Cell Line: OVCAR3) [3]
Crizotinib + Isoniazid DC47XP4 Crizotinib Astrocytoma (Cell Line: U251) [3]
Crizotinib + Isoniazid DCMV6GQ Crizotinib Glioma (Cell Line: SF-539) [3]
Crizotinib + Isoniazid DCD0GZR Crizotinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Crizotinib + Isoniazid DC4YEMQ Crizotinib Melanoma (Cell Line: UACC-257) [3]
Crizotinib + Isoniazid DCTTUJS Crizotinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Crizotinib + Isoniazid DC72ID3 Crizotinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Dacarbazine + Isoniazid DCG60J0 Dacarbazine Adenocarcinoma (Cell Line: HCC-2998) [3]
Dacarbazine + Isoniazid DCPBK5H Dacarbazine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [3]
Dacarbazine + Isoniazid DCJ8VFS Dacarbazine Malignant melanoma (Cell Line: LOX IMVI) [3]
Dacarbazine + Isoniazid DCP3VKW Dacarbazine Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
Dacarbazine + Isoniazid DCBC46Y Dacarbazine Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [3]
Dacarbazine + Isoniazid DCYUWMA Dacarbazine Colon carcinoma (Cell Line: KM12) [4]
Dexrazoxane + Isoniazid DC99003 Dexrazoxane Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Dexrazoxane + Isoniazid DCAAHOU Dexrazoxane Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Dexrazoxane + Isoniazid DCEBDA6 Dexrazoxane Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Dexrazoxane + Isoniazid DCCIOBK Dexrazoxane Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Dexrazoxane + Isoniazid DCI1FKJ Dexrazoxane Colon carcinoma (Cell Line: KM12) [4]
Dexrazoxane + Isoniazid DC3VX0E Dexrazoxane Adenocarcinoma (Cell Line: OVCAR3) [5]
Dexrazoxane + Isoniazid DCTKJ0P Dexrazoxane Adenocarcinoma (Cell Line: HT29) [5]
Dexrazoxane + Isoniazid DCWJVBZ Dexrazoxane Adenocarcinoma (Cell Line: HCC-2998) [5]
Dexrazoxane + Isoniazid DCOBXTZ Dexrazoxane Adenocarcinoma (Cell Line: HCT116) [5]
Dexrazoxane + Isoniazid DC8NYWU Dexrazoxane Adenocarcinoma (Cell Line: SW-620) [5]
Dexrazoxane + Isoniazid DCM75CL Dexrazoxane High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Epirubicin + Isoniazid DC0HA8Q Epirubicin Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Epirubicin + Isoniazid DCR3RWS Epirubicin Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Epirubicin + Isoniazid DCJVUR0 Epirubicin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Epirubicin + Isoniazid DCMHZKG Epirubicin Glioma (Cell Line: SF-268) [3]
Epirubicin + Isoniazid DC1R0YC Epirubicin Carcinoma (Cell Line: RXF 393) [4]
Epirubicin + Isoniazid DCBPK86 Epirubicin Carcinoma (Cell Line: MCF7) [4]
Epirubicin + Isoniazid DCOV6KY Epirubicin Adenocarcinoma (Cell Line: DU-145) [5]
Epirubicin + Isoniazid DC90KMW Epirubicin Adenocarcinoma (Cell Line: NCIH23) [5]
Epirubicin + Isoniazid DC6QYWN Epirubicin Adenocarcinoma (Cell Line: HCT116) [5]
Epirubicin + Isoniazid DCLLB4H Epirubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Epirubicin + Isoniazid DCY519Z Epirubicin Lung adenocarcinoma (Cell Line: EKVX) [5]
Epirubicin + Isoniazid DCO0N59 Epirubicin Malignant melanoma (Cell Line: UACC62) [5]
Epirubicin + Isoniazid DC39CLU Epirubicin Melanoma (Cell Line: UACC-257) [5]
Epirubicin + Isoniazid DCT6ZO4 Epirubicin Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Estramustine + Isoniazid DCG3DU6 Estramustine Glioma (Cell Line: SF-268) [3]
Estramustine + Isoniazid DCKXMZI Estramustine Breast adenocarcinoma (Cell Line: MDA-MB-468) [4]
Estramustine + Isoniazid DCSNZOI Estramustine Invasive ductal carcinoma (Cell Line: BT-549) [4]
Estramustine + Isoniazid DC11R6Z Estramustine Adenocarcinoma (Cell Line: DU-145) [5]
Estramustine + Isoniazid DCHKN3J Estramustine Adenocarcinoma (Cell Line: OVCAR3) [5]
Estramustine + Isoniazid DCZISWV Estramustine Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Estramustine + Isoniazid DCC99EB Estramustine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Estramustine + Isoniazid DCO6WU8 Estramustine Lung adenocarcinoma (Cell Line: HOP-62) [5]
Estramustine + Isoniazid DC0F79J Estramustine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Fludarabine + Isoniazid DC9CKMC Fludarabine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Fludarabine + Isoniazid DCVZR52 Fludarabine Adenocarcinoma (Cell Line: A549) [5]
FORMESTANE + Isoniazid DCHDF9Z FORMESTANE Adenocarcinoma (Cell Line: NCIH23) [3]
FORMESTANE + Isoniazid DCITE04 FORMESTANE Astrocytoma (Cell Line: U251) [3]
FORMESTANE + Isoniazid DC8R8B8 FORMESTANE Cutaneous melanoma (Cell Line: SK-MEL-5) [3]
FORMESTANE + Isoniazid DC2WWM3 FORMESTANE Glioblastoma (Cell Line: SNB-75) [3]
FORMESTANE + Isoniazid DCUVIL2 FORMESTANE Lung adenocarcinoma (Cell Line: HOP-62) [3]
FORMESTANE + Isoniazid DCIEZYE FORMESTANE Melanoma (Cell Line: MALME-3M) [3]
Fulvestrant + Isoniazid DCLOSJ1 Fulvestrant Adenocarcinoma (Cell Line: HT29) [3]
Fulvestrant + Isoniazid DCZ23K5 Fulvestrant Adenocarcinoma (Cell Line: HCT116) [3]
Fulvestrant + Isoniazid DCCDEQ2 Fulvestrant Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Fulvestrant + Isoniazid DCSQSIC Fulvestrant High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Fulvestrant + Isoniazid DC2HSE6 Fulvestrant Renal cell carcinoma (Cell Line: UO-31) [3]
Gefitinib + Isoniazid DCW3V3U Gefitinib Anaplastic large cell lymphoma (Cell Line: SR) [3]
Gefitinib + Isoniazid DCKD1Z2 Gefitinib Astrocytoma (Cell Line: SNB-19) [3]
Hepzato + Isoniazid DCS28GU Hepzato Glioblastoma (Cell Line: SNB-75) [3]
Hepzato + Isoniazid DC6UBWF Hepzato Carcinoma (Cell Line: RXF 393) [4]
Hepzato + Isoniazid DCQN42W Hepzato Malignant melanoma (Cell Line: UACC62) [5]
Hepzato + Isoniazid DCK7R6Q Hepzato Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Idarubicin + Isoniazid DCIA19K Idarubicin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Idarubicin + Isoniazid DCO2NE7 Idarubicin Glioblastoma (Cell Line: SNB-75) [3]
Idarubicin + Isoniazid DCJ1V8M Idarubicin Glioma (Cell Line: SF-539) [3]
Idarubicin + Isoniazid DCBWOB3 Idarubicin Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Idarubicin + Isoniazid DCNPKG5 Idarubicin Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
Idarubicin + Isoniazid DC5SFRT Idarubicin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Imatinib + Isoniazid DCGIUQ3 Imatinib Adenocarcinoma (Cell Line: HCT-15) [3]
Imatinib + Isoniazid DCRCBSS Imatinib Astrocytoma (Cell Line: U251) [3]
Imatinib + Isoniazid DCN1IEK Imatinib Chronic myelogenous leukemia (Cell Line: K-562) [3]
Indazole derivative 5 + Isoniazid DC9FLTK Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: A498) [3]
Indazole derivative 5 + Isoniazid DC2BWDJ Indazole derivative 5 Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Indazole derivative 5 + Isoniazid DC25YBC Indazole derivative 5 Renal cell carcinoma (Cell Line: UO-31) [3]
Indazole derivative 5 + Isoniazid DCDICLN Indazole derivative 5 Invasive ductal carcinoma (Cell Line: BT-549) [4]
Indazole derivative 5 + Isoniazid DC9J0VL Indazole derivative 5 Adenocarcinoma (Cell Line: OVCAR3) [5]
Indazole derivative 5 + Isoniazid DC8NFDA Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Indazole derivative 5 + Isoniazid DCUCZ50 Indazole derivative 5 High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Indazole derivative 5 + Isoniazid DC8XQL1 Indazole derivative 5 Melanoma (Cell Line: UACC-257) [5]
Indazole derivative 5 + Isoniazid DC0AZ5Z Indazole derivative 5 Melanoma (Cell Line: SK-MEL-2) [5]
Indazole derivative 5 + Isoniazid DC6SOKU Indazole derivative 5 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Isoniazid + Pentostatin DCDIGN1 Pentostatin Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Isoniazid + Pentostatin DC8TDVF Pentostatin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Isoniazid + Pentostatin DC87A1B Pentostatin Melanoma (Cell Line: SK-MEL-2) [3]
Isoniazid + Pentostatin DC87ESV Pentostatin Melanoma (Cell Line: UACC-257) [3]
Isoniazid + Cyclophosphamide DCAMQD0 Cyclophosphamide Adenocarcinoma (Cell Line: DU-145) [3]
Isoniazid + Cyclophosphamide DCXJ6N0 Cyclophosphamide Adenocarcinoma (Cell Line: HT29) [3]
Isoniazid + Cyclophosphamide DC5JYUE Cyclophosphamide Adenocarcinoma (Cell Line: SW-620) [3]
Isoniazid + Cyclophosphamide DCXXH9S Cyclophosphamide Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Isoniazid + Cyclophosphamide DCIAO1R Cyclophosphamide Amelanotic melanoma (Cell Line: MDA-MB-435) [3]
Isoniazid + Cyclophosphamide DCHYU0G Cyclophosphamide High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [3]
Isoniazid + Cyclophosphamide DCL8UCE Cyclophosphamide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Isoniazid + Cyclophosphamide DCSSP36 Cyclophosphamide Malignant melanoma (Cell Line: UACC62) [3]
Isoniazid + Cyclophosphamide DCMTQG8 Cyclophosphamide Renal cell carcinoma (Cell Line: UO-31) [3]
Isoniazid + Ifosfamide DCLVNF3 Ifosfamide Adenocarcinoma (Cell Line: A549) [3]
Isoniazid + Ifosfamide DCPIP3S Ifosfamide Adenocarcinoma (Cell Line: HCT116) [3]
Isoniazid + Ifosfamide DCW9DRG Ifosfamide Adenocarcinoma (Cell Line: HT29) [3]
Isoniazid + Ifosfamide DC43S33 Ifosfamide Anaplastic large cell lymphoma (Cell Line: SR) [3]
Isoniazid + Ifosfamide DCNQFXT Ifosfamide Lung adenocarcinoma (Cell Line: HOP-62) [3]
Isoniazid + Ifosfamide DC2J8N7 Ifosfamide Lung adenocarcinoma (Cell Line: MDA-MB-231) [3]
Isoniazid + Ifosfamide DC2TJ3M Ifosfamide Melanoma (Cell Line: SK-MEL-2) [3]
Isoniazid + Marizomib DCWWX9X Marizomib Diffuse intrinsic pontine glioma (Cell Line: DIPG25) [3]
Isoniazid + Mitomycin DC9P6GP Mitomycin Anaplastic large cell lymphoma (Cell Line: SR) [3]
Isoniazid + Mitomycin DCWBM3J Mitomycin Astrocytoma (Cell Line: SNB-19) [3]
Isoniazid + Mitomycin DC6WMKF Mitomycin Melanoma (Cell Line: SK-MEL-2) [3]
Isoniazid + Idarubicin DC9272Q Idarubicin Glioblastoma? (Cell Line: T98G) [3]
Isoniazid + Cisplatin DC1OIGC Cisplatin Astrocytoma (Cell Line: U251) [3]
Isoniazid + Cisplatin DCPXTEF Cisplatin Chronic myelogenous leukemia (Cell Line: K-562) [3]
Isoniazid + Cisplatin DCB3UXI Cisplatin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [3]
Isoniazid + Cisplatin DCTKL8S Cisplatin Melanoma (Cell Line: SK-MEL-2) [3]
Isoniazid + Chlorambucil DCG61LO Chlorambucil Adenocarcinoma (Cell Line: DU-145) [3]
Isoniazid + Chlorambucil DC67EU6 Chlorambucil Adenocarcinoma (Cell Line: HT29) [3]
Isoniazid + Chlorambucil DC2MUQO Chlorambucil Chronic myelogenous leukemia (Cell Line: K-562) [3]
Isoniazid + Chlorambucil DCKTQSG Chlorambucil Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Isoniazid + Chlorambucil DCXOYMY Chlorambucil Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Isoniazid + Chlorambucil DCTXFDY Chlorambucil Glioma (Cell Line: SF-295) [3]
Isoniazid + Chlorambucil DCO12LL Chlorambucil High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [3]
Isoniazid + Chlorambucil DC1HO8O Chlorambucil Large cell lung carcinoma (Cell Line: NCI-H460) [3]
Isoniazid + Chlorambucil DCN8WYO Chlorambucil Lung adenocarcinoma (Cell Line: EKVX) [3]
Isoniazid + Chlorambucil DC80FZ6 Chlorambucil Melanoma (Cell Line: UACC-257) [3]
Isoniazid + Chlorambucil DCCIG0C Chlorambucil Renal cell carcinoma (Cell Line: UO-31) [3]
Lapatinib + Isoniazid DCZWKXC Lapatinib Carcinoma (Cell Line: RXF 393) [4]
Lapatinib + Isoniazid DCVW745 Lapatinib Astrocytoma (Cell Line: SNB-19) [5]
Lapatinib + Isoniazid DC97C8S Lapatinib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Lapatinib + Isoniazid DCPODS1 Lapatinib Glioma (Cell Line: SF-295) [5]
Lapatinib + Isoniazid DCJA0GA Lapatinib Malignant melanoma (Cell Line: UACC62) [5]
Lenalidomide + Isoniazid DCOO0YZ Lenalidomide Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Lenalidomide + Isoniazid DC24XPK Lenalidomide Carcinoma (Cell Line: RXF 393) [4]
Lenalidomide + Isoniazid DCDI09W Lenalidomide Carcinoma (Cell Line: MCF7) [4]
Lenalidomide + Isoniazid DCXQDGW Lenalidomide Colon carcinoma (Cell Line: KM12) [4]
Lenalidomide + Isoniazid DCSOCMZ Lenalidomide Adenocarcinoma (Cell Line: HCC-2998) [5]
Lenalidomide + Isoniazid DC3XU0H Lenalidomide Amelanotic melanoma (Cell Line: M14) [5]
Lenalidomide + Isoniazid DCO7PX2 Lenalidomide Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Lenalidomide + Isoniazid DC3KFLW Lenalidomide Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Lenalidomide + Isoniazid DC8Z4VI Lenalidomide Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Letrozole + Isoniazid DCOH5JU Letrozole Adenocarcinoma (Cell Line: HT29) [3]
Letrozole + Isoniazid DCKNISM Letrozole Astrocytoma (Cell Line: U251) [3]
Letrozole + Isoniazid DCLGNS9 Letrozole Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Letrozole + Isoniazid DC767YJ Letrozole Glioma (Cell Line: SF-295) [3]
Letrozole + Isoniazid DC1H20R Letrozole Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [3]
LIAROZOLE + Isoniazid DCDEMIW LIAROZOLE Carcinoma (Cell Line: RXF 393) [4]
LIAROZOLE + Isoniazid DCY2ABY LIAROZOLE Adenocarcinoma (Cell Line: A549) [5]
Mechlorethamine + Isoniazid DC8ZEPY Mechlorethamine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Mechlorethamine + Isoniazid DCNL966 Mechlorethamine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mechlorethamine + Isoniazid DCO8HC7 Mechlorethamine Glioblastoma (Cell Line: SNB-75) [3]
Mechlorethamine + Isoniazid DC11IQ8 Mechlorethamine Colon carcinoma (Cell Line: KM12) [4]
Mechlorethamine + Isoniazid DCOD4LF Mechlorethamine Adenocarcinoma (Cell Line: HCC-2998) [5]
Mechlorethamine + Isoniazid DCXM42T Mechlorethamine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Mechlorethamine + Isoniazid DC0QV5A Mechlorethamine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Mepacrine + Isoniazid DCBK492 Mepacrine Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
Mepacrine + Isoniazid DCE6J7R Mepacrine Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Mepacrine + Isoniazid DCOE8K7 Mepacrine Glioma (Cell Line: SF-268) [3]
Mepacrine + Isoniazid DCKD3OX Mepacrine High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Mepacrine + Isoniazid DCOMFUV Mepacrine Malignant melanoma (Cell Line: UACC62) [5]
Mepacrine + Isoniazid DCIJNXN Mepacrine Malignant melanoma (Cell Line: LOX IMVI) [5]
Methotrexate + Isoniazid DCDMMTC Methotrexate Adenocarcinoma (Cell Line: HCT116) [3]
Methotrexate + Isoniazid DC6DYTX Methotrexate Melanoma (Cell Line: MALME-3M) [3]
Nilotinib + Isoniazid DC1G6IB Nilotinib Lung adenocarcinoma (Cell Line: EKVX) [5]
Nilotinib + Isoniazid DCZ8DRE Nilotinib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Picoplatin + Isoniazid DC7ESHP Picoplatin Astrocytoma (Cell Line: U251) [3]
Picoplatin + Isoniazid DC5X0MU Picoplatin Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
Picoplatin + Isoniazid DCC74TI Picoplatin Clear cell renal cell carcinoma (Cell Line: CAKI-1) [3]
Picoplatin + Isoniazid DCVXE2B Picoplatin Glioblastoma (Cell Line: SNB-75) [3]
Picoplatin + Isoniazid DCC3OKL Picoplatin Colon carcinoma (Cell Line: KM12) [4]
Picoplatin + Isoniazid DCNXCJL Picoplatin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Picoplatin + Isoniazid DC9P4L2 Picoplatin Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Picoplatin + Isoniazid DC8HXMK Picoplatin Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Picoplatin + Isoniazid DC4GUNG Picoplatin Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Picoplatin + Isoniazid DCEMKB3 Picoplatin Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Plicamycin + Isoniazid DCJWH6E Plicamycin Astrocytoma (Cell Line: SNB-19) [3]
Plicamycin + Isoniazid DCD0DFD Plicamycin Glioma (Cell Line: SF-539) [3]
Plicamycin + Isoniazid DC5U3GI Plicamycin Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Plicamycin + Isoniazid DCP4KP2 Plicamycin Renal cell carcinoma (Cell Line: SN12C) [3]
Plicamycin + Isoniazid DCAWGPP Plicamycin Carcinoma (Cell Line: RXF 393) [4]
Plicamycin + Isoniazid DCVNW9W Plicamycin Malignant melanoma (Cell Line: LOX IMVI) [5]
Plicamycin + Isoniazid DCR0ITM Plicamycin Prostate carcinoma (Cell Line: PC-3) [5]
PMID28870136-Compound-43 + Isoniazid DCJWBHL PMID28870136-Compound-43 Astrocytoma (Cell Line: U251) [3]
PMID28870136-Compound-43 + Isoniazid DCBCHWX PMID28870136-Compound-43 Glioma (Cell Line: SF-268) [3]
PMID28870136-Compound-43 + Isoniazid DC6GCLG PMID28870136-Compound-43 Glioma (Cell Line: SF-295) [3]
PMID28870136-Compound-43 + Isoniazid DCFL5CB PMID28870136-Compound-43 Adenocarcinoma (Cell Line: DU-145) [5]
PMID28870136-Compound-43 + Isoniazid DCQE331 PMID28870136-Compound-43 Adenocarcinoma (Cell Line: OVCAR3) [5]
PMID28870136-Compound-43 + Isoniazid DCTBDZM PMID28870136-Compound-43 Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
PMID28870136-Compound-43 + Isoniazid DCUOZTF PMID28870136-Compound-43 Lung adenocarcinoma (Cell Line: MDA-MB-231) [5]
PMID28870136-Compound-43 + Isoniazid DCTXTH4 PMID28870136-Compound-43 Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
PMID28870136-Compound-43 + Isoniazid DC5KLF3 PMID28870136-Compound-43 Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Pomalidomide + Isoniazid DCM2P3G Pomalidomide Adenocarcinoma (Cell Line: A549) [3]
Pomalidomide + Isoniazid DCZ38KL Pomalidomide Chronic myelogenous leukemia (Cell Line: K-562) [3]
Pomalidomide + Isoniazid DC3PFES Pomalidomide Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Pomalidomide + Isoniazid DCB20OR Pomalidomide Lung adenocarcinoma (Cell Line: NCI-H522) [3]
Pomalidomide + Isoniazid DCSINW6 Pomalidomide Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Pralatrexate + Isoniazid DCK1XAF Pralatrexate Astrocytoma (Cell Line: U251) [3]
Pralatrexate + Isoniazid DCLXPXN Pralatrexate Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Pralatrexate + Isoniazid DCCUEAX Pralatrexate Malignant melanoma (Cell Line: UACC62) [5]
Raloxifene + Isoniazid DCHETXK Raloxifene Anaplastic large cell lymphoma (Cell Line: SR) [3]
Raloxifene + Isoniazid DCX7R54 Raloxifene Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Raloxifene + Isoniazid DCD805I Raloxifene Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Raloxifene + Isoniazid DCQ9H2O Raloxifene Carcinoma (Cell Line: RXF 393) [4]
Raloxifene + Isoniazid DCIITGW Raloxifene Colon adenocarcinoma (Cell Line: COLO 205) [4]
Raloxifene + Isoniazid DC48WL3 Raloxifene Invasive ductal carcinoma (Cell Line: BT-549) [4]
Raloxifene + Isoniazid DCIPOCD Raloxifene Adenocarcinoma (Cell Line: NCIH23) [5]
Raloxifene + Isoniazid DCIR723 Raloxifene Adenocarcinoma (Cell Line: HCT-15) [5]
Raloxifene + Isoniazid DC7B9GT Raloxifene Amelanotic melanoma (Cell Line: M14) [5]
Raloxifene + Isoniazid DCKTUDT Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Raloxifene + Isoniazid DCM0TW6 Raloxifene Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Raloxifene + Isoniazid DC365LT Raloxifene High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5) [5]
Raloxifene + Isoniazid DCPVJG7 Raloxifene Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Raloxifene + Isoniazid DC3WPMG Raloxifene Lung adenocarcinoma (Cell Line: EKVX) [5]
Raloxifene + Isoniazid DCJZKW0 Raloxifene Melanoma (Cell Line: MALME-3M) [5]
Romidepsin + Isoniazid DCAMSG7 Romidepsin High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8) [5]
Ruxolitinib + Isoniazid DCT2NPX Ruxolitinib Astrocytoma (Cell Line: U251) [3]
Ruxolitinib + Isoniazid DCGUYDF Ruxolitinib Clear cell renal cell carcinoma (Cell Line: A498) [3]
Ruxolitinib + Isoniazid DCKKBVG Ruxolitinib Clear cell renal cell carcinoma (Cell Line: 786-0) [3]
Ruxolitinib + Isoniazid DC15CGY Ruxolitinib Glioma (Cell Line: SF-539) [3]
Ruxolitinib + Isoniazid DCYHQGZ Ruxolitinib Plasma cell myeloma (Cell Line: RPMI-8226) [3]
Ruxolitinib + Isoniazid DCZFKMQ Ruxolitinib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Ruxolitinib + Isoniazid DCKWN3Z Ruxolitinib Adenocarcinoma (Cell Line: DU-145) [5]
Ruxolitinib + Isoniazid DC6IIPI Ruxolitinib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Ruxolitinib + Isoniazid DCTM368 Ruxolitinib Melanoma (Cell Line: SK-MEL-2) [5]
Ruxolitinib + Isoniazid DC17XCP Ruxolitinib Melanoma (Cell Line: UACC-257) [5]
Ruxolitinib + Isoniazid DC0HFWB Ruxolitinib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Ruxolitinib + Isoniazid DCLZ1FX Ruxolitinib Prostate carcinoma (Cell Line: PC-3) [5]
SCH 727965 + Isoniazid DCTH1LK SCH 727965 Glioblastoma (Cell Line: SNB-75) [3]
SCH 727965 + Isoniazid DC631BG SCH 727965 Amelanotic melanoma (Cell Line: M14) [5]
SCH 727965 + Isoniazid DC6IEOO SCH 727965 Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Sorafenib + Isoniazid DCOV6ET Sorafenib Adenocarcinoma (Cell Line: DU-145) [3]
Sorafenib + Isoniazid DC839OR Sorafenib Adenocarcinoma (Cell Line: HCT116) [3]
Sorafenib + Isoniazid DCKYYI7 Sorafenib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Sorafenib + Isoniazid DCTD5KG Sorafenib Cutaneous melanoma (Cell Line: SK-MEL-28) [3]
Sorafenib + Isoniazid DCEQJBH Sorafenib Glioma (Cell Line: SF-268) [3]
SY-1425 + Isoniazid DCI4Y6E SY-1425 Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [3]
SY-1425 + Isoniazid DCGXGTN SY-1425 Astrocytoma (Cell Line: U251) [3]
SY-1425 + Isoniazid DCVA73C SY-1425 Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM) [3]
SY-1425 + Isoniazid DCBZ8GW SY-1425 Adenocarcinoma (Cell Line: HCT116) [5]
SY-1425 + Isoniazid DCCPNH1 SY-1425 High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
TEM + Isoniazid DC1WBZP TEM Glioblastoma (Cell Line: SNB-75) [3]
TEM + Isoniazid DC2XMES TEM Adenocarcinoma (Cell Line: A549) [5]
TEM + Isoniazid DCE2IVF TEM Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
TEM + Isoniazid DCCOI2U TEM Melanoma (Cell Line: MALME-3M) [5]
Terameprocol + Isoniazid DCCRWSG Terameprocol Glioma (Cell Line: SF-268) [3]
Terameprocol + Isoniazid DCBOY3W Terameprocol Adenocarcinoma (Cell Line: OVCAR3) [5]
Terameprocol + Isoniazid DCHL6R9 Terameprocol Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Terameprocol + Isoniazid DCGUF3M Terameprocol Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Thioguanine + Isoniazid DC2G2X4 Thioguanine Colon carcinoma (Cell Line: KM12) [4]
Thioguanine + Isoniazid DC8QBLN Thioguanine Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Topotecan + Isoniazid DCM5AYI Topotecan Carcinoma (Cell Line: MCF7) [4]
Topotecan + Isoniazid DCW7EIQ Topotecan Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Topotecan + Isoniazid DCR0MEM Topotecan Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Topotecan + Isoniazid DC7LO2F Topotecan Clear cell renal cell carcinoma (Cell Line: CAKI-1) [5]
Topotecan + Isoniazid DC1T0M7 Topotecan Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Topotecan + Isoniazid DCG5BHP Topotecan Glioblastoma (Cell Line: SNB-75) [5]
Topotecan + Isoniazid DCSL5IX Topotecan Glioma (Cell Line: SF-268) [5]
Topotecan + Isoniazid DCS0UWV Topotecan Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Topotecan + Isoniazid DCM67IG Topotecan Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1) [5]
Topotecan + Isoniazid DC92PKD Topotecan Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Topotecan + Isoniazid DC9925I Topotecan Pleural epithelioid mesothelioma (Cell Line: NCI-H226) [5]
Topotecan + Isoniazid DC3Q2KW Topotecan Prostate carcinoma (Cell Line: PC-3) [5]
Triapine + Isoniazid DCNBUZ3 Triapine Colon carcinoma (Cell Line: KM12) [4]
Triapine + Isoniazid DCTGQB0 Triapine Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Triapine + Isoniazid DCMGN94 Triapine Glioma (Cell Line: SF-539) [5]
Triapine + Isoniazid DCM8MT5 Triapine High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Triapine + Isoniazid DCWQK8V Triapine Large cell lung carcinoma (Cell Line: NCI-H460) [5]
Triapine + Isoniazid DCFP78M Triapine Malignant melanoma (Cell Line: LOX IMVI) [5]
Triapine + Isoniazid DCNK7V7 Triapine Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Triapine + Isoniazid DCMW4DW Triapine Prostate carcinoma (Cell Line: PC-3) [5]
Trifluridine + Isoniazid DCQNV1Z Trifluridine Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [3]
Trifluridine + Isoniazid DC7H53D Trifluridine Clear cell renal cell carcinoma (Cell Line: TK-10) [3]
Trifluridine + Isoniazid DCGI3NO Trifluridine Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Trifluridine + Isoniazid DC8O6DY Trifluridine Lung adenocarcinoma (Cell Line: EKVX) [5]
Uracil mustard + Isoniazid DCNFE0J Uracil mustard High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Valrubicin + Isoniazid DCHLG0S Valrubicin Clear cell renal cell carcinoma (Cell Line: A498) [3]
Valrubicin + Isoniazid DCA743E Valrubicin Glioma (Cell Line: SF-295) [3]
Valrubicin + Isoniazid DC3S835 Valrubicin Adenocarcinoma (Cell Line: HT29) [5]
Valrubicin + Isoniazid DCNP9JU Valrubicin Amelanotic melanoma (Cell Line: MDA-MB-435) [5]
Valrubicin + Isoniazid DC6QVKX Valrubicin High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Vandetanib + Isoniazid DCSJ5JU Vandetanib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vandetanib + Isoniazid DCC47IA Vandetanib Adenocarcinoma (Cell Line: HCC-2998) [5]
Vandetanib + Isoniazid DCI23QT Vandetanib Clear cell renal cell carcinoma (Cell Line: TK-10) [5]
Vandetanib + Isoniazid DCWHA02 Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-28) [5]
Vandetanib + Isoniazid DCPSVSO Vandetanib Cutaneous melanoma (Cell Line: SK-MEL-5) [5]
Vandetanib + Isoniazid DCJSPZJ Vandetanib Glioma (Cell Line: SF-268) [5]
Vandetanib + Isoniazid DCTTD03 Vandetanib Melanoma (Cell Line: SK-MEL-2) [5]
Vandetanib + Isoniazid DCQRN17 Vandetanib Plasma cell myeloma (Cell Line: RPMI-8226) [5]
Vemurafenib + Isoniazid DC52GNO Vemurafenib Carcinoma (Cell Line: MCF7) [4]
Vemurafenib + Isoniazid DCWEDQC Vemurafenib Colon carcinoma (Cell Line: KM12) [4]
Vemurafenib + Isoniazid DCYIF6I Vemurafenib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vemurafenib + Isoniazid DCSWD66 Vemurafenib Adenocarcinoma (Cell Line: DU-145) [5]
Vemurafenib + Isoniazid DCYK8VN Vemurafenib Adenocarcinoma (Cell Line: OVCAR3) [5]
Vemurafenib + Isoniazid DCQ8L2Z Vemurafenib Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4) [5]
Vemurafenib + Isoniazid DCYHZSK Vemurafenib Astrocytoma (Cell Line: SNB-19) [5]
Vemurafenib + Isoniazid DCI4L74 Vemurafenib Glioblastoma (Cell Line: SNB-75) [5]
Vemurafenib + Isoniazid DCBPQ9F Vemurafenib Glioma (Cell Line: SF-268) [5]
Vemurafenib + Isoniazid DCZZTRP Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4) [5]
Vemurafenib + Isoniazid DC07G84 Vemurafenib High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES) [5]
Vemurafenib + Isoniazid DC6HNLZ Vemurafenib Melanoma (Cell Line: SK-MEL-2) [5]
Vemurafenib + Isoniazid DCP8TWE Vemurafenib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vemurafenib + Isoniazid DCQU80E Vemurafenib Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3) [5]
Vemurafenib + Isoniazid DCMRWDA Vemurafenib Prostate carcinoma (Cell Line: PC-3) [5]
Vemurafenib + Isoniazid DCDOKSM Vemurafenib Renal cell carcinoma (Cell Line: SN12C) [5]
Vinflunine + Isoniazid DC4CDYW Vinflunine Glioma (Cell Line: SF-295) [3]
Vinflunine + Isoniazid DC85A4C Vinflunine Minimally invasive lung adenocarcinoma (Cell Line: NCI-H322M) [5]
Vismodegib + Isoniazid DC6C548 Vismodegib Carcinoma (Cell Line: MCF7) [4]
Vismodegib + Isoniazid DC9WTP9 Vismodegib Invasive ductal carcinoma (Cell Line: BT-549) [4]
Vismodegib + Isoniazid DC9YJEA Vismodegib Invasive ductal carcinoma (Cell Line: HS 578T) [4]
Vismodegib + Isoniazid DCW4C9A Vismodegib Adenocarcinoma (Cell Line: DU-145) [5]
Vismodegib + Isoniazid DCOAJH4 Vismodegib Adenocarcinoma (Cell Line: HCC-2998) [5]
Vismodegib + Isoniazid DCODV48 Vismodegib Adult acute myeloid leukemia (Cell Line: HL-60(TB)) [5]
Vismodegib + Isoniazid DC4N0ZV Vismodegib Astrocytoma (Cell Line: SNB-19) [5]
Vismodegib + Isoniazid DCXAORJ Vismodegib Clear cell renal cell carcinoma (Cell Line: 786-0) [5]
Vismodegib + Isoniazid DCXLBQA Vismodegib Clear cell renal cell carcinoma (Cell Line: A498) [5]
Vismodegib + Isoniazid DCPA77I Vismodegib Glioblastoma (Cell Line: SNB-75) [5]
Vismodegib + Isoniazid DCBEABS Vismodegib Glioma (Cell Line: SF-539) [5]
Vismodegib + Isoniazid DCDUGKW Vismodegib Glioma (Cell Line: SF-268) [5]
Vismodegib + Isoniazid DCO21YI Vismodegib Melanoma (Cell Line: UACC-257) [5]
Vismodegib + Isoniazid DCX0GWS Vismodegib Melanoma (Cell Line: SK-MEL-2) [5]
Vismodegib + Isoniazid DCWVPU4 Vismodegib Non-small cell lung carcinoma (Cell Line: HOP-92) [5]
Vismodegib + Isoniazid DCJZ9SC Vismodegib Papillary renal cell carcinoma (Cell Line: ACHN) [5]
Vismodegib + Isoniazid DCPGN9E Vismodegib Renal cell carcinoma (Cell Line: SN12C) [5]
------------------------------------------------------------------------------------
⏷ Show the Full List of 380 DrugCom(s)
13 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Isoniazid + Methadone DCE3BTD Methadone Opioid Dependence [6]
Isoniazid + Rifapentine DCRMHA9 Rifapentine HIV Infections [7]
Isoniazid + Rifapentine DCW9U5X Rifapentine Tuberculosis [8]
Isoniazid + Misoprostol DCZE4W4 Misoprostol IUCD Complication [9]
MK-1439 + Isoniazid DCZBO4J MK-1439 Latent Tuberculosis [10]
Pyrazinamide + Isoniazid DC9I6BF Pyrazinamide HIV Infections [11]
Rifampicin + Isoniazid DCJ2QX2 Rifampicin HIV Infections [7]
Rifabutin + Isoniazid DC6OKQQ Rifabutin Tuberculosis [12]
Isoniazid + Fluconazole DC1V49W Fluconazole Human Immunodeficiency Virus [13]
Isoniazid + Rifapentine DC5O6NC Rifapentine Tuberculosis, Pulmonary [14]
Pyrazinamide + Isoniazid DC23JKL Pyrazinamide Tuberculosis [15]
Pyrazinamide + Isoniazid DC9AJPI Pyrazinamide Tuberculosis [15]
Pyrazinamide + Isoniazid DCM3RK9 Pyrazinamide Tuberculosis, Pulmonary [14]
------------------------------------------------------------------------------------
⏷ Show the Full List of 13 DrugCom(s)

References

1 Isoniazid FDA Label
2 Novel agents in the management of Mycobacterium tuberculosis disease. Curr Med Chem. 2007;14(18):2000-8.
3 Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
4 Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.
5 Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
6 ClinicalTrials.gov (NCT03089983) Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings
7 ClinicalTrials.gov (NCT00057122) Tuberculosis Prevention for HIV Infected Adults
8 ClinicalTrials.gov (NCT01404312) Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB)
9 ClinicalTrials.gov (NCT04500002) Isonicotinic Acid Hydrazide (INH) Pretreatment With Misoprostol Versus Misoprostol Alone in Missed Abortion
10 ClinicalTrials.gov (NCT03886701) Doravirine, Rifapentine and Isoniazid Interaction
11 ClinicalTrials.gov (NCT00042289) Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy
12 ClinicalTrials.gov (NCT03891901) A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and Rifabutin
13 ClinicalTrials.gov (NCT01825031) Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy
14 ClinicalTrials.gov (NCT05454345) Sitafloxacin-containing Regimens for Shortening Tuberculosis Treatment
15 ClinicalTrials.gov (NCT02563327) Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis